If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

I tested seven sleep patches from three top brands, but only a few lived up to the hype. Here's everything you need to know ...

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion.

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

As part of this integration, consumers who use both Dexcom glucose biosensors, including its over-the-counter product Stelo, ...

“The technology is now changing people’s lives,” Shen said.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.